Literature DB >> 1618759

The cDNA for the type I iodothyronine 5'-deiodinase encodes an enzyme manifesting both high Km and low Km activity. Evidence that rat liver and kidney contain a single enzyme which converts thyroxine to 3,5,3'-triiodothyronine.

J Sharifi1, D L St Germain.   

Abstract

The enzymatic conversion of thyroxine (T4) to 3,5,3-triiodothyronine (T3) by iodothyronine 5'-deiodinase(s) is an obligate step in the physiologic action of thyroid hormones in most extrathyroidal tissues. In the rat liver and kidney, 5'-deiodinase processes having either high Km (micromolar range) or low Km (nanomolar range) values for thyroid hormone substrates have been described. The number of enzymes mediating these reactions, however, remains uncertain and controversial. To examine this question we have compared the 5'-deiodinase activity expressed in membrane preparations of Xenopus laevis oocytes after the injection of either rat liver poly(A)+ RNA or in vitro prepared RNA transcribed using the G21 full-length type I 5'-deiodinase cDNA. In oocytes injected with rat liver poly(A)+ RNA, high Km (i.e. type I) activity was observed when 20 mM dithiothreitol was used as the thiol cofactor, whereas Km values in the nanomolar range were noted with 0.5 mM dithiothreitol, glutathione, or a reconstituted thioredoxin cofactor system. This complex pattern of 5'-deiodinase activity, which mimics that found in homogenates and subcellular fractions of rat liver and kidney, was reproduced exactly in oocytes by the microinjection of G21-derived RNA transcripts. Furthermore, hybrid arrest of translation in oocytes using a partial type I 5'-deiodinase cDNA completely inhibited the expression of both high and low Km activity after the injection of rat liver poly(A)+ RNA. These findings demonstrate that rat liver and kidney contain only a single 5'-deiodinase which manifests either high or low Km activity depending on the reduced thiol cofactor utilized in the reaction.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1618759

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  The 5'-deiodinases are not essential for the fasting-induced decrease in circulating thyroid hormone levels in male mice: possible roles for the type 3 deiodinase and tissue sequestration of hormone.

Authors:  Valerie Anne Galton; Arturo Hernandez; Donald L St Germain
Journal:  Endocrinology       Date:  2014-03-17       Impact factor: 4.736

2.  Cloning of the mammalian type II iodothyronine deiodinase. A selenoprotein differentially expressed and regulated in human and rat brain and other tissues.

Authors:  W Croteau; J C Davey; V A Galton; D L St Germain
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

3.  Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans.

Authors:  Ana Luiza Maia; Brian W Kim; Stephen A Huang; John W Harney; P Reed Larsen
Journal:  J Clin Invest       Date:  2005-08-25       Impact factor: 14.808

4.  IL-6 promotes nonthyroidal illness syndrome by blocking thyroxine activation while promoting thyroid hormone inactivation in human cells.

Authors:  Simone Magagnin Wajner; Iuri Martin Goemann; Ana Laura Bueno; P Reed Larsen; Ana Luiza Maia
Journal:  J Clin Invest       Date:  2011-04-11       Impact factor: 14.808

5.  Substitution of serine for proline in the active center of type 2 iodothyronine deiodinase substantially alters its in vitro biochemical properties with dithiothreitol but not its function in intact cells.

Authors:  Iuri Martin Goemann; Balázs Gereben; John W Harney; Bo Zhu; Ana Luiza Maia; P Reed Larsen
Journal:  Endocrinology       Date:  2009-12-04       Impact factor: 4.736

6.  A thyroid hormone-regulated gene in Xenopus laevis encodes a type III iodothyronine 5-deiodinase.

Authors:  D L St Germain; R A Schwartzman; W Croteau; A Kanamori; Z Wang; D D Brown; V A Galton
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-02       Impact factor: 11.205

7.  Extensions, validation, and clinical applications of a feedback control system simulator of the hypothalamo-pituitary-thyroid axis.

Authors:  Marisa Eisenberg; Mary Samuels; Joseph J DiStefano
Journal:  Thyroid       Date:  2008-10       Impact factor: 6.568

8.  Knockdown of the type 3 iodothyronine deiodinase (D3) interacting protein peroxiredoxin 3 decreases D3-mediated deiodination in intact cells.

Authors:  Goele Aerts; Rafael Arrojo E Drigo; Stijn L J Van Herck; Eva Sammels; Delphine Mirebeau-Prunier; Balázs Gereben; Anikó Zeöld; John W Harney; Stephen A Huang; Michelle A Mulcahey; Serge Van der Geyten; Gert Van den Bergh; Lut Arckens; Veerle M Darras; Ann Marie Zavacki
Journal:  Endocrinology       Date:  2009-10-09       Impact factor: 4.736

9.  Life without thyroxine to 3,5,3'-triiodothyronine conversion: studies in mice devoid of the 5'-deiodinases.

Authors:  Valerie Anne Galton; Mark J Schneider; Ann S Clark; Donald L St Germain
Journal:  Endocrinology       Date:  2009-02-05       Impact factor: 4.736

10.  American Thyroid Association Guide to investigating thyroid hormone economy and action in rodent and cell models.

Authors:  Antonio C Bianco; Grant Anderson; Douglas Forrest; Valerie Anne Galton; Balázs Gereben; Brian W Kim; Peter A Kopp; Xiao Hui Liao; Maria Jesus Obregon; Robin P Peeters; Samuel Refetoff; David S Sharlin; Warner S Simonides; Roy E Weiss; Graham R Williams
Journal:  Thyroid       Date:  2013-12-12       Impact factor: 6.568

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.